# Vera Therapeutics, Inc.: filings

VERA · Nasdaq · CIK 1831828 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vera.md) · [Financials](/companies/vera/financials.md) · [Filings](/companies/vera/filings.md) · [Insiders](/companies/vera/insiders.md)

## Reports and events: 107 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 192, 8-K 63, 144 32, 3 30, SC 13G/A 18, 10-Q 17, 424B5 12, SC 13G 11, CORRESP 9, SC 13D/A 9, SCHEDULE 13G/A 7, 4/A 6, DEFA14A 6, S-8 6, 10-K 5, DEF 14A 5, SCHEDULE 13G 5, UPLOAD 5, ARS 4, EFFECT 3, SC 13D 3, 424B4 2, DRS 2, S-1 2, S-1/A 2, SEC STAFF LETTER 2, 8-A12B 1, CERT 1, D 1, S-1MEF 1, S-3 1, S-3ASR 1, S-3MEF 1, SCHEDULE 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-15 | 06:45 ET | [8-K](/filings/0001193125-26-391280.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-391280 |
| 2026-08-10 | 16:10 ET | [10-Q](/filings/0001193125-26-342380.md) | Quarterly report, period 2026-06-30 | 0001193125-26-342380 |
| 2026-08-10 | 16:05 ET | [8-K](/filings/0001193125-26-342335.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-342335 |
| 2026-07-09 | 08:00 ET | [8-K](/filings/0001193125-26-299165.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-299165 |
| 2026-07-07 | 12:45 ET | [8-K](/filings/0001193125-26-297211.md) | 8.01 Other events | 0001193125-26-297211 |
| 2026-06-02 | 07:05 ET | [8-K](/filings/0001193125-26-252475.md) | 8.01 Other events | 0001193125-26-252475 |
| 2026-05-26 | 16:54 ET | [8-K](/filings/0001193125-26-239559.md) | 5.07 Shareholder vote results | 0001193125-26-239559 |
| 2026-05-07 | 16:33 ET | [10-Q](/filings/0001193125-26-212143.md) | Quarterly report, period 2026-03-31 | 0001193125-26-212143 |
| 2026-05-07 | 07:30 ET | [8-K](/filings/0001193125-26-210351.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-210351 |
| 2026-04-09 | 16:05 ET | [DEF 14A](/filings/0001140361-26-014002.md) | Proxy statement, period 2026-05-21 | 0001140361-26-014002 |
| 2026-03-09 | 17:01 ET | [8-K](/filings/0001193125-26-098783.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-098783 |
| 2026-03-05 | 06:11 ET | [SCHEDULE 13D/A](/filings/0001104659-26-023756.md) | Ownership report, active investor, amended | 0001104659-26-023756 |
| 2026-02-26 | 17:25 ET | [10-K](/filings/0001193125-26-077442.md) | Annual report, period 2025-12-31 | 0001193125-26-077442 |
| 2026-02-26 | 07:30 ET | [8-K](/filings/0001193125-26-073421.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-073421 |
| 2025-12-18 | 19:50 ET | [8-K](/filings/0001193125-25-323298.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-323298 |
| 2025-12-10 | 17:18 ET | [8-K](/filings/0001193125-25-314430.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-314430 |
| 2025-11-26 | 16:30 ET | [8-K](/filings/0001193125-25-300647.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-300647 |
| 2025-11-06 | 09:59 ET | [8-K](/filings/0001193125-25-268331.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-268331 |
| 2025-11-05 | 16:06 ET | [10-Q](/filings/0001193125-25-266881.md) | Quarterly report, period 2025-09-30 | 0001193125-25-266881 |
| 2025-11-05 | 08:00 ET | [8-K](/filings/0001193125-25-265799.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-265799 |
| 2025-08-05 | 16:56 ET | [8-K](/filings/0001193125-25-173591.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-173591 |
| 2025-08-05 | 16:06 ET | [10-Q](/filings/0000950170-25-103022.md) | Quarterly report, period 2025-06-30 | 0000950170-25-103022 |
| 2025-08-05 | 07:30 ET | [8-K](/filings/0000950170-25-102399.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-102399 |
| 2025-06-03 | 06:36 ET | [8-K](/filings/0001193125-25-133730.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-133730 |
| 2025-06-02 | 06:36 ET | [8-K](/filings/0001193125-25-132736.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-132736 |
| 2025-05-19 | 16:41 ET | [8-K](/filings/0000950170-25-074446.md) | 5.07 Shareholder vote results | 0000950170-25-074446 |
| 2025-05-07 | 18:22 ET | [10-Q](/filings/0000950170-25-064733.md) | Quarterly report, period 2025-03-31 | 0000950170-25-064733 |
| 2025-05-06 | 08:00 ET | [8-K](/filings/0000950170-25-063975.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-063975 |
| 2025-04-03 | 16:06 ET | [DEF 14A](/filings/0001140361-25-012034.md) | Proxy statement, period 2025-05-14 | 0001140361-25-012034 |
| 2025-02-28 | 16:00 ET | [10-K](/filings/0000950170-25-029969.md) | Annual report, period 2024-12-31 | 0000950170-25-029969 |
| 2025-02-26 | 08:00 ET | [8-K](/filings/0000950170-25-027337.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-027337 |
| 2025-01-13 | 08:06 ET | [8-K](/filings/0001193125-25-005010.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-005010 |
| 2024-11-07 | 16:00 ET | [10-Q](/filings/0000950170-24-123239.md) | Quarterly report, period 2024-09-30 | 0000950170-24-123239 |
| 2024-11-07 | 08:00 ET | [8-K](/filings/0000950170-24-122814.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-122814 |
| 2024-11-04 | 19:49 ET | [SC 13D/A](/filings/0001193125-24-250796.md) | Ownership report, active investor, amended | 0001193125-24-250796 |
| 2024-10-31 | 06:05 ET | [8-K](/filings/0001193125-24-248079.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-248079 |
| 2024-10-28 | 17:30 ET | [8-K](/filings/0001193125-24-245704.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-245704 |
| 2024-10-02 | 09:01 ET | [8-K](/filings/0001193125-24-230760.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-230760 |
| 2024-08-08 | 16:36 ET | [10-Q](/filings/0000950170-24-094108.md) | Quarterly report, period 2024-06-30 | 0000950170-24-094108 |
| 2024-08-08 | 08:00 ET | [8-K](/filings/0000950170-24-093342.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-093342 |
| 2024-07-02 | 16:05 ET | [8-K](/filings/0001193125-24-174318.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-174318 |
| 2024-06-12 | 16:05 ET | [8-K](/filings/0001193125-24-159935.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-159935 |
| 2024-05-17 | 17:15 ET | [8-K](/filings/0000950170-24-061872.md) | 5.07 Shareholder vote results | 0000950170-24-061872 |
| 2024-05-10 | 17:40 ET | [10-Q](/filings/0000950170-24-057292.md) | Quarterly report, period 2024-03-31 | 0000950170-24-057292 |
| 2024-05-09 | 07:30 ET | [8-K](/filings/0000950170-24-056283.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-056283 |
| 2024-04-03 | 17:00 ET | [DEF 14A](/filings/0001140361-24-017650.md) | Proxy statement, period 2024-05-15 | 0001140361-24-017650 |
| 2024-03-27 | 20:35 ET | [10-K](/filings/0000950170-24-036729.md) | Annual report, period 2023-12-31 | 0000950170-24-036729 |
| 2024-03-26 | 19:57 ET | [SC 13D/A](/filings/0001104659-24-039188.md) | Ownership report, active investor, amended | 0001104659-24-039188 |
| 2024-03-20 | 07:30 ET | [8-K](/filings/0000950170-24-033947.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-033947 |
| 2024-02-20 | 19:11 ET | [SC 13D/A](/filings/0001104659-24-025676.md) | Ownership report, active investor, amended | 0001104659-24-025676 |

Page 1 of 3. [Older](/companies/vera/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.